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Abstract
Pseudomonas aeruginosa is an opportunistic Gram‐negative bacterium that is primarily
responsible for infections related to cystic fibrosis (CF) airways, burn wounds, urinary
tract infections, surgery‐associated infections, and HIV‐related illness. Pyocyanin and
extracellular DNA (eDNA) are the major factors dictating the progression of biofilm
formation and infection. Pyocyanin is a potent virulence factor causing cell death in
infected CF patients and is associated with high mortality. eDNA is a key player in P.
aeruginosa biofilm formation and is also responsible for the high viscosity of CF sputum
that blocks the respiratory airway passages. In this chapter, we summarize our recent
findings  on  the  role  of  pyocyanin  in  facilitating  P.  aeruginosa  biofilm  formation.
Pyocyanin promotes eDNA release in P. aeruginosa by inducing cell lysis mediated via
hydrogen peroxide (H2O2)  production. Pyocyanin intercalates with the nitrogenous
bases  of  DNA  and  creates  structural  perturbation  on  the  double‐helix  structure.
Pyocyanin‐eDNA binding significantly influences P. aeruginosa cell surface hydropho‐
bicity and influences the physicochemical interactions facilitating bacterial cell‐to‐cell
interaction  (aggregation)  and  ultimately  facilitates  robust  biofilm  formation.  A
pyocyanin knockout (ΔphzA‐G) mutant is shown to have significantly reduced eDNA
release and biofilm formation in comparison to its wild‐type. To this end, we discover
that antioxidant glutathione directly binds to pyocyanin and modulates pyocyanin
structure and function, thus inhibiting pyocyanin‐eDNA binding and consequently
hampering biofilm development.
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film
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1. Introduction
Pseudomonas aeruginosa is an opportunistic Gram‐negative bacterium that readily forms biofilms
and  causes  life‐threatening  infections,  particularly  in  immunocompromised  persons.  P.
aeruginosa is primarily responsible for infections related to airways in cystic fibrosis (CF) and
bronchiectasis, burns wounds, urinary tract infections (UTIs), and nosocomial infections. For
instance, P. aeruginosa infection and subsequent biofilm formation is implicated in 80% of CF
deaths worldwide [1]. In CF patients, P. aeruginosa infection is responsible for lung tissue damage,
impaired lung function, respiratory failure, and premature death [1, 2]. In spite of intensive
antibiotic therapy against infections, the mean life expectancy of CF patients is short (∼45 years)
[1]. A recent study suggests that P. aeruginosa and its associated infections are more persistent
and dominant in CF patients aged over 18 years (91%) than in patients less than 18 years (39%)
[3]. In the case of burn injury infections, P. aeruginosa along with Staphylococcus aureus are
recognized as principal pathogens responsible for serious complications in ∼20.9% and 22.9%
of patients, respectively [4]. Studies suggest that, in the United States, approximately 2.5 million
patients with burn injury requires medical attention in which it is estimated more than 100,000
hospitalizations  result  every  year,  causing  approximately  12,000  deaths  from associated
infections [5]. In hospital‐acquired UTIs, P. aeruginosa is the third most common pathogen next
to Escherichia coli and Proteus mirabilis [6]. In United States, UTI‐associated hospital admission
is estimated to be 300,000 patients every year, and urological disease costs more than 3.5 billion
dollars annually in the United States alone [6].
Persistent P. aeruginosa infections that culminate in biofilm formation are attributed to a matrix
of extracellular polymeric substances (EPS) in which bacterial cells are embedded [7, 8]. The
EPS matrix of P. aeruginosa primarily consists of biomolecules, such as polysaccharides
(alginate, lipopolysaccharides), proteins (protease, elastase), extracellular DNA (eDNA),
metabolites (phenazines), exotoxin, and siderophores [6, 7]. These molecules present in the
matrix play a significant role in the pathogenesis of P. aeruginosa infections. In addition, in
many bacterial species, the matrix as a whole provides an inherent protection against both host
immunity and traditional antibiotic therapy, which makes eradication extremely difficult [7,
9]. Previous studies acknowledge that the production of phenazines such as pyocyanin and
the release of DNA from cells, providing freely available eDNA by P. aeruginosa, are the major
factors dictating the formation of a biofilm and the persistent infection within the host [7, 8,
10, 11]. For instance, P. aeruginosa‐infected CF and bronchitis sputum contains a significant
amount of pyocyanin (up to 16 and 23 μg/ml, respectively) and eDNA (3–14 mg/ml) compared
to none in non‐CF patients [11, 12]. Pyocyanin is a highly versatile molecule recognized for its
effect as a potent virulence factor, causing cell death in chronically infected CF patients and
directly associated with decreased lung function and high mortality [11, 13]. eDNA is similarly
a key factor in P. aeruginosa biofilm formation and protecting bacteria by inducing antibiotic
resistance [8, 14, 15] and is also a contributing factor to the high viscosity of CF sputum that
blocks the respiratory airway passages [12].
In this chapter, we focus our discussion on very recent findings that elucidate the essential role
of pyocyanin in promoting eDNA production and interacting with eDNA to facilitate biofilm
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formation in P. aeruginosa. To this end, we highlight novel strategies targeting the interaction
of pyocyanin with eDNA to prevent P. aeruginosa biofilm formation.
2. Pyocyanin production by P. aeruginosa
P. aeruginosa synthesizes a variety of phenazines; however, the most abundantly produced is
pyocyanin [5‐methyl‐1(5H)‐phenazinone]. Up to 95% of P. aeruginosa isolates preferentially
produce pyocyanin [16], which at a neutral pH is a distinctive blue in color and turns red in
acidic pH conditions. It is a small and highly diffusible nitrogen‐containing aromatic com‐
pound with a multitude of biological activities [16, 17]. In P. aeruginosa, pyocyanin production
involves a stepwise process, beginning with the synthesis of the primary quorum sensing (QS)
Figure 1. (a) Schematic of phenazine (pyocyanin) production by P. aeruginosa. Pyocyanin production is triggered at the
early stationary phase through QS molecules (AHL and PQS), phenazine‐producing genes (phzA‐G), and finally by
gene phzM. (b) Pyocyanin production by various P. aeruginosa clinical (AES‐1, AES‐2, and LESB58) and laboratory
(PA14 wild‐type, ΔphzA‐G, PAO1 wild‐type, and ΔphzSH) strains at different (0, 8, 16, and 24 h) time points. Error bars
represent standard deviations from the mean (n=4).
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molecule N‐acyl‐L‐homoserine lactone (AHL) during the exponential growth phase followed
by the secondary QS molecule Pseudomonas quinolone signaling (PQS) during the late expo‐
nential phase. PQS directly controls the expression of phzA‐G operons resulting in the pro‐
duction of phenazine‐1‐carboxylic acid (PCA) from its precursor chorismic acid. PCA is then
modified to produce three metabolites during the early stationary phase of which pyocyanin
is the predominant product and is regulated by the phzM gene. The two other types of
phenazine products are phenazine‐1‐carboxamide (PCN; encoded by phzH) and 1‐hydroxy‐
phenazine (1‐OHPHZ; encoded by phzS) [16, 18] (Figure 1a).
Figure 1b shows pyocyanin production by various P. aeruginosa clinical (AES‐1R, AES‐2, and
LESB58) and laboratory (PA14 wild‐type, ΔphzA‐G, PAO1 wild‐type, and PAO1 phzSH) strains
at different time points (0, 8, 16, and 24 h) grown under planktonic conditions in Luria broth
(LB) at 37°C and 150 rpm (unpublished data). The cell‐free supernatant of various bacterial
strains was used to quantify pyocyanin by absorbance at 691 nm. A standard curve for
pyocyanin was generated by addition of a known concentration (0–150 μM) of purified
pyocyanin (Sigma‐Aldrich, USA) to LB medium in a 1 ml cuvette, and absorbance was assayed
at 691 nm (λmax of pyocyanin) using Bio‐Rad Smartspec 3000 (Bio‐Rad Laboratories, Australia).
This curve was used to calibrate pyocyanin concentration in bacterial supernatants. For most
of the P. aeruginosa strains (AES‐1R, AES‐2, LESB58, PA14 wild‐type, PAO1 wild‐type, and
PAO1 phzSH) used in this study, at initial growth stage (8 h postinoculation), the concentration
of pyocyanin produced was less than 5 μM followed by a significant increase in pyocyanin
production recorded at ≥16 h of growth and reaching between 75 and 100 μM pyocyanin for
AES‐1R, LESB58, PA14 wild‐type, and PAO1 phzSH strains and ∼140 μM pyocyanin for AES‐
2 strain after 24 h growth, whereas PAO1 wild‐type produces less than (<) 15 μM pyocyanin.
In contrast, the phzSH mutant of PAO1, which is deficient of phzS and phzH genes, was unable
to convert PCA to PCN or 1‐OHPHZ [16, 19] and consequently overproduced pyocyanin,
whereas, after 24 h, phenazine‐deficient mutant (ΔphzA‐G) does not produce any pyocyanin.
3. Pyocyanin a virulence factor
Pyocyanin was formerly disregarded as a bacterial secondary metabolite but has recently been
ascribed a variety of roles in microbial ecology, and importantly a relationship with the severity
of P. aeruginosa infections [20]. Previous research has shown a correlation between pyocyanin
concentration in CF sputum and severity of infection [20]. The role of pyocyanin has been
intensively studied due to its electrochemical and redox activity. The diffusible nature of
pyocyanin means that it can easily diffuse through the host cell membrane and undergo redox
reactions with other molecules [2]. For instance, it accepts electrons from NADH and subse‐
quently donates electrons to molecular oxygen to form reactive oxygen species (ROS), such as
hydrogen peroxide (H2O2) [13]. The H2O2 generated via redox reactions has been identified as
a potent inhibitor of other bacterial and fungal species found within the microbiome of the CF
lung as well as significantly altering host cell functions [2, 21]. In CF patients, pyocyanin‐
mediated ROS oxidize host intracellular and extracellular reduced glutathione (GSH) to form
glutathione disulfide or oxidized glutathione (GSSG; Figure 2) [13].
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Figure 2. (a) Oxidation of GSH to GSSG by pyocyanin. P. aeruginosa produces pyocyanin, and pyocyanin accepts elec‐
trons (e−) from NADH and donates these electrons to oxygen to generate H2O2. Glutathione also donates electrons to
H2O2 forming GSSG. (b) Structure of pyocyanin, GSH, and GSSG.
Depleted GSH levels during the chronic stage of CF infection leads to widespread epithelial
cell death and consequently lung damage, respiratory failure, and mortality [21, 22]. Pyocyanin
also inhibits catalase activity in the airway epithelial cells and thus aggravates oxidative stress
in lung epithelial cells [23].
4. Pyocyanin promotes eDNA release in P. aeruginosa via H2O2 generation
In bacteria, eDNA release is mediated by both lytic and nonlytic mechanisms. The lytic
mechanism involves the controlled lysis of a small number of bacterial cells via the production
of various QS‐mediated cell lysing agents, such as lytic prophages, autolysin proteins,
enzymes, and H2O2. In nonlytic mechanisms, eDNA release is through bacterial outer mem‐
brane blebs/vesicles that contain large amounts of DNA [24–26]. QS‐dependent mechanisms
involve the AHL and PQS systems, whereas QS‐independent mechanisms operate via release
through flagellum and type IV pili [27, 28]. PQS in P. aeruginosa PAO1, a virulent laboratory
strain, triggers eDNA release in the early phase of planktonic culture through the induction
of prophages [27]. In accordance, a mutant for QS synthesis in pqsA and a pqsL mutant that
overproduces PQS show low and high amounts of eDNA release, respectively [27]. QS‐
independent mechanisms, which also include phage induction [28], are responsible for eDNA
release only in well‐established PAO1 biofilms (>10 days) and not in planktonic cultures.
A recent work in this field by Das and Manefield has shown that pyocyanin production in P.
aeruginosa laboratory strains PAO1 and PA14 triggers a significant increase in eDNA release
Role of Pyocyanin and Extracellular DNA in Facilitating Pseudomonas aeruginosa Biofilm Formation
http://dx.doi.org/10.5772/63497
27
[19]. Quantitative analysis of eDNA in PA14 wild‐type (120 h grown in LB medium) cell‐free
supernatant showed ∼20 to 25 μg eDNA/ml. In contrast, cell‐free supernatant of pyocyanin‐
deficient mutant of PA14 (ΔphzA‐G) produced 50% less eDNA. Interestingly, ΔphzA‐G culture
grown in the presence of exogenous addition of pyocyanin showed significant increase in
eDNA release [19]. In another study, Steinberger and Holden recorded up to 220 and 500 mg
eDNA/g of cellular DNA in 5‐day‐old biofilms of P. aeruginosa and Pseudomonas putida,
respectively; however, their study did not compare the link between pyocyanin and eDNA
production in P. aeruginosa and P. putida [29].
In general, phenazines such as pyocyanin induce H2O2 production and subsequently trigger
cell death in host (mammalian) and competing fungal and bacterial cells are well documented.
A recent study showed concrete evidence of P. aeruginosa strains producing the highest
concentrations of pyocyanin generated the highest concentrations of H2O2 [19]. The production
of H2O2 initiates ∼7 to 14% increase in cell lysis in planktonic cultures of P. aeruginosa and
consequently promotes eDNA release. Figure 3 shows a schematic of pyocyanin‐mediated
eDNA release via H2O2 in P. aeruginosa. H2O2‐mediated eDNA release is not limited to P.
aeruginosa strains; for instance, in oral Gram‐positive bacteria (Streptococcus sanguinis),
pyruvate oxidase activity induces ∼10% increase in cell death in its own population via H2O2
production and consequently facilitates eDNA release [30].
Figure 3. Schematic showing pyocyanin‐mediated release of eDNA via H2O2 production.
By examining pyocyanin production in different strains of P. aeruginosa in relation to H2O2
generation, cell lysis, and eDNA concentration, a clear relationship emerged. The findings in
this study demonstrate that pyocyanin is involved in eDNA release in growing P. aeruginosa
planktonic cultures, raising interesting questions about its role in biofilm biology. Pyocyanin‐
mediated eDNA production, which likely happens as a consequence of cell lysis via H2O2
generation, could possibly assist P. aeruginosa biofilm formation in several ways, as eDNA has
been shown to be an essential biomolecule that necessitates the establishment of P. aerugino‐
sa biofilm [7, 8]. Previous studies suggest that the production of phenazines enhance bacterial
adhesion, microcolony formation, and increased biomass in P. aeruginosa biofilms and current
generations of P. aeruginosa PA14 in bioelectrochemical systems [31, 32]. From previous
findings in concurrence with the current results, we hypothesized that the phenazine pyocya‐
nin may promote biofilm formation in P. aeruginosa via eDNA release through H2O2‐mediated
cell lysis. However, the exact mechanism of how pyocyanin facilitates P. aeruginosa biofilm
formation is yet to be elucidated.
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5. Pyocyanin binding to eDNA
Previous studies have demonstrated that eDNA is a key constituent in the construction and
structural integrity of the biofilm matrix in many bacterial species, and the cleaving of eDNA
by nuclease enzymes such as DNase I disintegrates the biofilm matrix, thereby increasing the
susceptibility of bacterial cells within the biofilm matrix to antimicrobial agents such as
detergents and antibiotics [33, 34]. eDNA acts as a scaffold for the whole biofilm by binding
with other biomolecules such as peptides/enzymes/proteins and polysaccharides. For exam‐
ple, in Streptococcus mutans, an oral pathogen responsible for dental plaques, the competence
stimulating peptide (CSP) and DNA‐binding protein ComGB interact with eDNA, and this
interaction is essential for the uptake of eDNA by S. mutans, which facilitates bacterial cell‐to‐
cell interaction and biofilm formation [35]. In another example, HU and IHF (DNA‐binding
proteins) produced by human pathogenic bacterium E. coli strain U93 specifically bind to
double‐stranded DNA (dsDNA) in the EPS, and by binding with eDNA, such proteins generate
specific structures within eDNA. The enzymatic digestion of these proteins makes eDNA lose
its structural stability and thereby disrupts E. coli biofilms [36]. In Listeria monocytogenes, a food‐
borne pathogen, eDNA binding with N‐acetylglucosamine, a type of peptidoglycan, has been
shown to be an essential molecular interaction that initiates L. monocytogenes adhesion to
surfaces [37]. To our knowledge, our discovery was the first to demonstrate that, apart from
biopolymers such as proteins and polysaccharides, a secondary metabolite such as pyocyanin
strongly binds with DNA to dictate the establishment of P. aeruginosa biofilm.
5.1. Mechanism of pyocyanin‐DNA binding
The mechanism of pyocyanin‐eDNA binding was elucidated using different types of spectro‐
scopic techniques by Das et al. [10]. In this study, we used P. aeruginosa pyocyanin (Sigma‐
Aldrich, USA) and calf thymus DNA sodium salt (type I fibers; 42% GC content; Sigma‐
Figure 4. Mechanism of pyocyanin‐DNA binding using spectroscopic techniques. (a) Fluorescence emission spectro‐
scopy techniques show that pyocyanin displaces EtBr bound to dsDNA, indicating that pyocyanin is an intercalating
agent. (b) UV‐vis spectra of DNA with pyocyanin showed that hyperchromic (increase in absorbance intensity) and
hypochromic (shift in wavelength of DNA peak from 259 to 253 nm) effects are indicative of the intercalation of pyo‐
cyanin between nitrogenous base pairs of DNA and exposure of nitrogenous base pairs due to the unwinding of the
DNA helix. (c) CD spectra of DNA‐pyocyanin mixtures confirm that DNA binds to pyocyanin. The increase in mdeg at
277 nm in DNA peak confirms that pyocyanin intercalates into the nitrogenous bases of DNA, whereas the shift in
DNA peak at 247 nm to 244, 243, and 242 nm in the presence of 28, 143, and 286 μM pyocyanin, respectively, confirms
that pyocyanin also binds to sugar‐phosphate backbone of DNA.
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Aldrich, USA), which has predominantly dsDNA (∼90%) quantified using Qubit fluorescent
dye assay and Qubit 2.0 Fluorometer (Invitrogen, USA) as mentioned previously.
Using fluorescence emission spectroscopy (Varian Cary Eclipse Fluorescence Spectrophotom‐
eter, USA), it was found that pyocyanin displaces ethidium bromide (EtBr) bound to dsDNA.
All experiments were done in SHE buffer (2 mM HEPES, 10 μM EDTA, and 9.4 mM NaCl in
Milli‐Q water adjusted to pH 7 with NaOH). Light emission at 615 nm (λex=480 nm) was
quantified at room temperature in 1 ml quartz cuvette. The fluorescence emission spectra
suggest that the addition of pyocyanin (70 or 140 μM) reduced the DNA (6 ng/μl)‐EtBr (4 μM)
peak maxima to that of an EtBr solution without DNA (Figure 4a). It is well known that EtBr
is a classic intercalating agent that strongly binds to DNA via intercalation and the displace‐
ment of EtBr by pyocyanin suggests that pyocyanin can bind to DNA. However, the mecha‐
nism of pyocyanin‐DNA binding was not immediately clear.
To determine the binding mechanism between pyocyanin and DNA, a Varian Cary 100 Bio
UV‐visible (UV‐vis) spectrophotometer technique was used [10]. UV‐vis spectroscopic scans
from 200 to 800 nm were performed in 1 ml quartz cuvette on DNA, pyocyanin, and the DNA‐
pyocyanin complex in Milli‐Q water. Figure 4b shows the UV‐vis range spectra of DNA (50
ng/μl) in the presence of increasing concentrations of pyocyanin (5.6, 11.2, 16.8, or 28.0 μM).
The spectra of DNA with pyocyanin showed a gradual increase in absorbance intensity of the
DNA peak and a shift of the DNA peak from 259 to 253 nm with increasing pyocyanin
concentrations. The observed hyperchromic (due to the increase in absorbance intensity) and
hypochromic (due to the shift in wavelength of DNA peak) effects are indicative of the
intercalation of pyocyanin between nitrogenous base pairs of DNA and exposure of nitroge‐
nous base pairs due to the unwinding of the DNA helix [38].
The pyocyanin‐DNA binding mechanism was further confirmed using a Chirascan circular
dichroism (CD) spectrophotometer (Applied Photophysics, UK). The experiments were
conducted using 1 mm path length quartz cuvette, and mixtures of dsDNA at 135 ng/μl with
varying pyocyanin (0, 28, 143, and 286 μM) concentrations in 350 μl Milli‐Q water were scanned
from 200 to 320 nm after a 15‐min static incubation at 25°C. The spectra of DNA‐pyocyanin
mixtures confirm that DNA binds to pyocyanin with statistically significant changes in peak
intensity (P<0.05) at all four characteristic DNA peaks (209, 221, 247, and 277 nm) achieved
with pyocyanin concentrations above 28 μM. The significant increase in mdeg at 277 nm in
DNA peak is a clear confirmation that pyocyanin intercalates into the nitrogenous bases of
DNA. Additionally, the shift in DNA peak at 247 nm to 244, 243, and 242 nm in the presence
of 143 and 286 μM pyocyanin, respectively (Figure 4c) show that pyocyanin also binds to sugar‐
phosphate backbone of DNA and therein creates local perturbations in the DNA double‐helix
structure but, however, does not cause any significant transition in form (i.e. B‐DNA to A or
Z form).
5.2. Pyocyanin‐eDNA binding influences P. aeruginosa cell surface hydrophobicity and
physicochemical interactions
Pyocyanin is well known as an electron shuttle [18], and our recent investigation revealed that
pyocyanin intercalates with DNA [10]. In line with this, previous studies revealed that eDNA
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promotes bacterial aggregation through acid‐base interactions involving electron‐donating
and electron‐accepting groups [39]. Contact angle measurements on various Gram‐positive
and Gram‐negative bacterial cell surfaces revealed that eDNA significantly influences
modulation in bacterial cell surface hydrophobicity [8, 39]. For instance, the cell surface of
Streptococcus epidermidis 1457 wild‐type is more hydrophobic in the presence of eDNA (average
water contact angle of 85°), whereas S. epidermidis 1457 ∆atlE (eDNA‐deficient mutant) and
DNase I (DNA cleaving enzyme)‐treated S. epidermidis 1457 wild‐type showed significant
reduction in the water contact angle (39–44°) [39]. Based on these findings, we hypothesized
that pyocyanin is involved in facilitating eDNA binding to P. aeruginosa cells and thus possibly
influences P. aeruginosa cell surface properties such as hydrophobicity and surface energies
and consequently influences physicochemical interactions.
The hypothesis was tested by measuring contact angles of P. aeruginosa PA14 and PAO1 lawn
growths prepared by the deposition of bacteria, from a planktonic suspension, onto a 0.2 μm
pore diameter filter (nitrocellulose membrane filter; Millipore, USA) using negative pressure
[39, 40]. Contact angles were measured with standard polar (water and formamide) and
nonpolar (diiodomethane) liquids using goniometer (KSV model 200; KSV Instrumentation
Pvt. Ltd., Finland) following the sessile drop technique [39]. To remove eDNA, P. aeruginosa
strains were treated with DNase I before lawn preparation and its contact angle was measured
as above. DNase I untreated P. aeruginosa PA14 and PAO1 wild‐type showed significantly
higher degree of water contact angle in comparison to untreated ∆phzA‐G. After DNase I
treatment only, the wild‐type strains showed a significant decrease in the water contact angle
and ultimately equivalent to the water contact angle of the ∆phzA‐G mutant (Figure 5a) [40].
This result demonstrates that the interaction of pyocyanin with eDNA modulates cell surface
hydrophobicity in P. aeruginosa.
Figure 5. (a) Effect of DNase I and pyocyanin on P. aeruginosa cell surface hydrophobicity. The removal of eDNA by
DNase I treatment shows a significant decrease in cell surface hydrophobicity (water contact angle) on all pyocyanin‐
producing strains, whereas pyocyanin‐deficient strain (∆phzA‐G) showed no change in the water contact angle regard‐
less of DNase I treatment. (b) Gibbs free energy of aggregation indicates that the removal of eDNA or the absence of
pyocyanin significantly declines the efficiency of P. aeruginosa cell‐to‐cell aggregation. Error bars represent standard
deviations from the mean (n=3). Asterisks indicate statistical significance (Student's t‐test P<.05) in comparison to
DNase I treatment. PA14 strain data are taken from Das et al. [40], whereas PAO1 contact angle and Gibbs free energy
of aggregation results are unpublished.
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The modulation in P. aeruginosa cell surface hydrophobicity has shown a direct impact on
bacterial surface energy components as determined using theoretical surface thermodynamics
(Figure 5b). Surface thermodynamics elucidated the physicochemical interactions that are
responsible for bacterial cell‐to‐cell interactions at close approach. Physicochemical interac‐
tions are nonspecific interactions forces that derive from molecules that are present on the
bacterial cell surface. In our study, pyocyanin and eDNA are the molecules that facilitate
attractive physicochemical interactions such as short‐range acid‐base and long‐range Lifshitz‐
van der Waals interactions. The removal of eDNA from P. aeruginosa wild‐type cell surface or
the absence of pyocyanin in ∆phzA‐G mutant strain showed significant impact (i.e. nonattrac‐
tive interaction, especially on the short‐range acid‐base interaction, which includes electron‐
donating and electron‐accepting parameters). However, the long‐range Lifshitz‐van der Waals
interactions remained unaffected between wild‐type and ∆phzA‐G regardless of DNase I
treatment [40]. Another important parameter that commonly exists and drives bacterial
interactions includes the presence of biopolymers (DNA, polysaccharides, and proteins) and
cell appendages (pili, fimbriae) that extend hundreds of nanometers from the cell surface [41].
These biopolymers/appendages initiate hydrogen bonding by colliding with its neighboring
cells and thereby help bacterial cells to overcome small physicochemical energy barrier and
promote bacterial cell‐to‐cell interactions [7, 41].
5.3. Pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation
eDNA was previously acknowledged as a biofilm‐promoting factor, whereas pyocyanin was
mainly considered as a secondary metabolite essential for the persistence of P. aeruginosa cells
in highly dense biofilm by enabling maintenance of a basal rate of respiration for energy
harvesting and to maintain cytoplasmic redox homeostasis [18]. From our previous investi‐
gation, it was revealed that pyocyanin‐eDNA binding influences essential physicochemical
interactions that drive bacterial cell‐to‐cell interactions. Such findings prompted the hypoth‐
eses that pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation.
P. aeruginosa PA14 wild‐type and ΔphzA‐G mutant biofilm formation was investigated on a
glass substratum using confocal laser scan microscopy (CLSM) technique complemented using
ImageJ software to quantify biofilm characteristic properties (Figure 6). Biofilm growth,
staining, imaging, and analysis were performed using the protocol described previously [10].
Comparative studies were undertaken between biofilms (grown for 24 h in LB medium, 37°C,
150 rpm) of wild‐type (Figure 6a and b) and ΔphzA‐G (Figure 6c and d) grown in the absence
and presence of DNase I. Findings indicated that P. aeruginosa PA14 biofilm architecture,
thickness, and biofilm biomass in wild‐type biofilms grown in the presence of DNase I are
similar in biofilms of a phenazine‐deficient mutant strain (Table 1). The removal of eDNA
reduced wild‐type biofilm thickness and biomass by ∼40% and 65%, respectively, whereas
phenazine‐deficient mutant also showed ∼40% reduction in biofilm thickness and up to 80%
reduction in biomass. This result clearly indicates that the influence of eDNA on developing
a three‐dimensional and structurally integrated biofilm is equivalent to the influence of
pyocyanin on biofilm.
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Figure 6. Confocal microscopy imaging of P. aeruginosa PA14 strains. (a) PA14 wild‐type, (b) PA14 wild‐type grown in
the presence of DNase I (40 U), (c) ΔphzA‐G, (d) ΔphzA‐G in the presence of DNase I (40 U), (e) ΔphzA‐G in the presence
of exogenous pyocyanin (200 μM), and (f) ΔphzA‐G in the presence of exogenous DNA (1 ng/μl) and exogenous pyo‐
cyanin (200 μM).
P. aeruginosa Thickness (μm) Biomass (μm3/μm2)
Wild‐type 8.3±0.3 1.4±0.4
Wild‐type+DNase I (40 U) 5.2±1.5 0.5±0.1
ΔphzA‐G 4.9±0.4 0.3±0.1
ΔphzA‐G+DNase I (40 U) 3.9±0.5 0.3±0.3
ΔphzA‐G+pyocyanin (200 μM) 7.2±1.0 0.6±0.2
ΔphzA‐G+pyocyanin (200 μM)+DNA (1 ng/μl) 7.9±0.4 1.0±0.1
Table 1. Quantification of P. aeruginosa (nonestablished) biofilm properties using ImageJ software. Significant
differences were observed in biofilm thickness and biomass between control (PA14 wild‐type) and wild‐type grown in
the presence of DNase I (40 U) and ΔphzA‐G regardless of whether they were grown in the presence of DNase I. Mean
±standard deviations (n=3). Boldfaced data indicate that the differences were statistically significant (Student's t‐test
P<0.05) in comparison to control (wild‐type), whereas boldfaced italicized data indicate that the thickness and biomass
of ΔphzA‐G grown in the presence of pyocyanin and the combination of pyocyanin+DNA is significantly (Student's t‐
test P<0.05) higher than the biofilm of ΔphzA‐G alone (control).
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A previous study by Ramos et al. also showed similar results with phenazine‐deficient mutant
but could not elucidate the mechanism behind the influence of phenazine on biofilm formation
in P. aeruginosa [30]. This finding is compatible with the hypothesis that eDNA and pyocyanin
act in concert to influence P. aeruginosa biofilm formation, with a direct interaction between
pyocyanin and eDNA likely underlying the mechanism of enhanced biofilm integrity. The fact
that biofilm formation in the phenazine‐deficient mutant is partly restored by the addition of
exogenous pyocyanin (Figure 6e), with the addition of both exogenous pyocyanin and DNA
showed further enhancement in biofilms in comparison to the pyocyanin only treatment
(Figure 6f). This suggests that this particular phenazine is partly, but not wholly, responsible
for the phenomenon, and that interaction with eDNA is an essential factor to facilitate biofilm
formation.
6. Glutathione disrupts P. aeruginosa biofilm formation
With the increased tolerance of bacteria to existing antibiotic therapies [1] and the necessity to
use high doses of antibiotics with their related side effects [42, 43], there is an urgent public
health priority to identify new methods and targets for the control of P. aeruginosa biofilms.
6.1. Glutathione interacts with pyocyanin and inhibits its binding with eDNA
GSH is a thiol tripeptide (γ‐glutamylcysteinylglycine) found in all human cells and in some
bacterial species. GSH is considered to be a master antioxidant and its primary functions
include defense against ROS and free radicals and maintaining a healthy immune system [13].
In humans, intracellular GSH levels vary from 2 to 10 mM, whereas, in the extracellular lung
lining fluid (ELF), levels range from 250 to 800 μM [44]. In contrast, intracellular GSH concen‐
tration in bacterial cell differs significantly from species to species [45–47]. For instance, in E.
coli, GSH is an essential molecule and exists in the millimolar range [47], whereas, in P.
aeruginosa PAO1, intracellular GSH concentration is reported in the nanomolar range (70 nM)
[46]. However, in many Gram‐positive bacteria such as Bacillus cereus, GSH is not found [45, 48].
Pyocyanin undergoes oxidation by donating electron to molecular oxygen to form superoxides
and H2O2 [49]. GSH, being a thiol antioxidant, will donate electron/protons to pyocyanin
directly through the ‐SH group from cysteine [50], thereby interfering in the pyocyanin
oxidation process by inhibiting H2O2 generation [50]. The antioxidant property of GSH makes
it a potential inhibitor of pyocyanin toxicity.
Our recent investigation using CD and UV‐vis suggests that pyocyanin‐GSH complex
interferes with pyocyanin binding to DNA (Figure 7a and b) [10], whereas nuclear magnetic
resonance (NMR; Bruker Avance 400 spectrometer) of the pyocyanin-GSH complex at various
pyocyanin‐GSH ratios clearly indicates that GSH (with at least fivefold higher concentration
than pyocyanin) is required to modulate pyocyanin aromatic structure (Figure 7c; unpublished
data). As discussed earlier, pyocyanin is a planar molecule that intercalates into the nitroge‐
nous base of DNA. By instead conjugating with GSH, intercalation with DNA is restricted.
However, it is interesting to observe that with the increases in GSH concentration, the
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inhibition of pyocyanin binding to DNA is increased; almost complete inhibition was observed
at a molar ratio of pyocyanin/GSH of ∼1:6. A similar observation was reported recently by
Muller and Merrett [50] demonstrating that thiol concentration needs to be available in the
millimolar range to neutralize pyocyanin toxicity. Their work also suggests that GSH forms a
cell‐impermanent conjugate with pyocyanin. This suggests that thiol antioxidants could be a
potential clinical target against P. aeruginosa toxicity by preventing pyocyanin entry into host
cells and prohibiting pyocyanin‐mediated cell lysis.
Figure 7. Inhibition of pyocyanin intercalation with DNA. (a) CD spectra of DNA‐pyocyanin‐GSH mixtures confirm
that GSH inhibits pyocyanin intercalation with DNA; however, the inhibition is GSH concentration dependent. At
above 1000 μM, GSH (which is ∼1:9 ratio to pyocyanin concentration used in this study) successfully inhibits pyocya‐
nin intercalation to DNA nitrogenous base (peak 277 nm) and binding to DNA backbone (peak at 244 nm). (b) UV‐vis
spectra of DNA with pyocyanin‐GSH complex inhibit the shift of wavelength of DNA peak (i.e. retained DNA peak at
259 nm) indicative of the absence of hypochromic effect, which indicates no intercalation. (c) Proton NMR spectra of
pyocyanin (100 μM)‐GSH (50, 100, 500, or 1000 μM) mixtures indicated a considerable downfield shift of the pyocya‐
nin aromatic peaks. However, this shift was observed only at higher GSH (i.e. at 500 and 1000 μM) concentration ratios
(i.e. at pyocyanin/GSH 1:5 and 1:10), whereas, at low GSH (i.e. at 50 and 100 μM) concentrations, pyocyanin aromatic
peaks remain stable.
6.2. Glutathione disrupts clinical strains of P. aeruginosa biofilms and facilitates
bactericidal activity
Biophysical techniques confirmed that GSH inhibits pyocyanin‐eDNA intercalation. This
made us to hypothesize that GSH could disrupt biofilms, as pyocyanin and eDNA are the
crucial factors that initiate biofilm formation. Our recent investigation confirmed that inter‐
rupting the pyocyanin‐eDNA intercalation using GSH results in a significant disruption of the
biofilms of pathogenic Australian epidemic strain (AES‐1R and AES‐1M isolated from a CF
patient; unpublished data). Figure 8 shows the effect of GSH, DNase I treatment (12 h, 37°C,
150 rpm) on preestablished biofilms grown in LB medium (24 h, 37°C, 150 rpm) imaged using
CLSM.
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An analysis of biofilm image using ImageJ software revealed that GSH or DNase I‐treated
AES‐1R and AES‐1M biofilm showed significant difference (Student's t‐test P>0.05) of ∼30 to
40% and 60 to 80% reduction in its biofilm thickness and total biofilm biomass, respectively
(Table 2). This shows that eDNA and pyocyanin are vital molecules in the building of biofilms
of clinical strains of P. aeruginosa, and by modulating pyocyanin structure and function, biofilm
formation can be restrained while concomitantly reducing the toxicity of pyocyanin.
Figure 8. Confocal microscopy imaging of 24 h preestablished biofilms of P. aeruginosa clinical strains AES‐1R and
AES‐1M. (a) AES‐1R (control), (b) AES‐1R treated with 2 mM GSH, (c) AES‐1R treated with DNase I (40 U), (d) AES‐
1M (control), (e) AES‐1M treated with 2 mM GSH, and (f) AES‐1M treated with DNase I (40 U).
P. aeruginosa Treatment Thickness (μm) Biomass (μm3/μm2) Average Live/Dead (%)
AES‐1R — 8.6±1.1 1.8±0.4 83/17
AES‐1R GSH (2 mM) 5.1±0.8 0.5±0.2 37/63
AES‐1R DNase I (40 U) 4.9±1.0 0.7±0.3 84/16
AES‐1M — 7.4±1.4 1.1±0.3 79/21
AES‐1M GSH (2 mM) 4.1±0.7 0.7±0.4 12/88
AES‐1M DNase I (40 U) 3.9±0.6 0.2±0.1 93/7
Table 2. Quantification of P. aeruginosa (24 h preestablished) biofilm properties using ImageJ software. Significant
differences were observed in biofilm thickness, biomass, and average percentage of live and dead biomass between
control (AES‐1R and AES‐1M) and GSH (2 mM) or DNase I (40 U)‐treated biofilms. Mean±standard deviations (n=3).
Boldfaced data indicate that the differences were statistically significant (Student's t‐test P<0.05) in comparison to
control.
Biofilm image (Figure 8) and quantification of live (green) and dead (red) biofilm biomass
(Table 2) clearly show significant increase in dead biomass when biofilm exposed to GSH
treatment. GSH‐mediated bactericidal activity in P. aeruginosa is proposed through the
generation of H2O2 via the auto‐oxidation of GSH (Figure 8). H2O2 generation by GSH was
quantified using Amplex red H2O2 assay kit (Thermo Fisher Scientific, USA) as per manufac‐
turer's instruction using multi‐well plate reader (Perkin‐Elmer, USA). About 11.5 μM H2O2
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was generated by 2 mM GSH after 4 h; this finding supports previous published work that
suggested that GSH undergoes auto‐oxidation to produce H2O2 [51–53]. In biological system
of healthy individuals, the production of catalase and other chelating agents inhibits the
oxidation stress generated by the auto‐oxidation of GSH [52]; however, in infected patients,
pyocyanin inhibits catalase activity in lung epithelial cells [23] and consequently inhibits the
protection against oxidative stress generated by all kinds of endogenous and exogenous
molecules.
7. Conclusion and perspective
Bacterial biofilms form a highly protective biological matrix that enables persisting popula‐
tions of bacteria to survive in otherwise highly hostile environments. These matrices vary
highly between species; however, they share a common structural element (eDNA). Within P.
aeruginosa, eDNA is both necessary and sufficient for structured biofilm formation and
maintenance. We have demonstrated that eDNA enhances intercellular aggregation by
reducing the Gibbs free energy between cells while also enhancing hydrophobicity by
increasing the water contact angle. Furthermore, these properties are enhanced by the presence
of the virulence factor pyocyanin, which is able to directly bind to nitrogenous base pairs
within dsDNA by mode of intercalation. Pyocyanin is uniquely produced by P. aeruginosa and
as such confers a unique method by which P. aeruginosa is able to strengthen its biofilm.
Biofilm formation is associated with increased resistance to antibiotic therapies and persistence
of bacterial colonization within the CF lung. Novel treatment strategies seek to act on molecules
that are essential for bacterial persistence such as biofilm constituents. Biofilm disruption is
associated with increased antibiotic susceptibility and the clearance of bacteria. We have
shown that, by disrupting the biofilm association with thiol‐based antioxidants, namely GSH,
which directly binds and clears freely available pyocyanin, intercellular aggregation and
overall biofilm structure are perturbed. This is enhanced by the activity of nucleases such as
DNase I, which remove the underlying eDNA scaffold, resulting in a complete disruption of
the biofilm structure by decreasing the water contact angle of bacterial cells and increasing the
Gibbs free energy between cells.
Thus, the intercalation between pyocyanin and eDNA is both a unique and highly exploitable
interaction in P. aeruginosa biofilms, and this interaction is necessary for any kind of structured
biofilm architecture in P. aeruginosa. By exploring the disruption of this interaction, both GSH
and DNase I have arisen as potential therapeutic candidates for the elimination of persistent
infections of P. aeruginosa existing as a biofilm. This is particularly useful for long‐term host‐
adapted strains of P. aeruginosa, such as those persisting in the CF lung, which typically develop
a multidrug‐resistant profile as the result of repeated antibiotic therapies.
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